Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Terumo BCT Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (45)
ARTG (24)
Prescription medicine registration (2)
Australian Public Assessment Report (AusPAR) (1)
Prescription medicine decision summary (1)

Date

2024 (6)
2023 (10)
2022 (2)
2021 (2)
2020 (16)
2019 (5)
2018 (4)
2017 (12)
2015 (1)
2014 (5)
2007 (1)
2006 (8)
2005 (1)

Results for "[search-keyword]"

Search

Sponsor content

73 result(s) found, displaying 31 to 40

Terumo BCT Australia Pty Ltd - Cell culture bioreactor Cancelled under Section 41GL(d) of the Act

26 June 2020

Cancellation by sponsor

Requested by Terumo BCT Australia Pty Ltd
Terumo BCT Australia Pty Ltd - Blood collection/cell-culture container Cancelled under Section 41GL(d) of the Act

26 June 2020

Cancellation by sponsor

Requested by Terumo BCT Australia Pty Ltd
Terumo BCT Australia Pty Ltd - Blood donor set, double-pack Cancelled under Section 41GL(d) of the Act

26 June 2020

Cancellation by sponsor

Requested by Terumo BCT Australia Pty Ltd
Terumo BCT Australia Pty Ltd - Blood collection tubing set (303188)

18 May 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Terumo BCT Australia Pty Ltd - Blood collection tubing set.
Terumo BCT Australia Pty Ltd - Apheresis system tubing set (301729)

10 April 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Terumo BCT Australia Pty Ltd - Apheresis system tubing set.
Terumo BCT Australia Pty Ltd - Photopheresis system blood set Cancelled under Section 41GL(d) of the Act

28 February 2020

Cancellation by sponsor

Requested by Terumo BCT Australia Pty Ltd
Terumo BCT Australia Pty Ltd - Photopheresis system lamp assembly Cancelled under Section 41GL(d) of the Act

28 February 2020

Cancellation by sponsor

Requested by Terumo BCT Australia Pty Ltd
Terumo BCT Australia Pty Ltd - Photopheresis system Cancelled under Section 41GL(d) of the Act

28 February 2020

Cancellation by sponsor

Requested by Terumo BCT Australia Pty Ltd
Uvadex

13 December 2019

Prescription medicine decision summary

Australian prescription medicine decision summary
AusPAR: Methoxsalen

14 November 2019

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Methoxsalen

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.